Cargando…
Candidate Markers of Olaparib Response from Genomic Data Analyses of Human Cancer Cell Lines
SIMPLE SUMMARY: Olaparib is an oral medication typically used to treat certain advanced ovarian and breast cancers with mutations in BRCA1 or BRCA2 genes. Mutations in these genes can increase the risk of developing breast, ovarian, and other types of cancer. Olaparib is the first clinically approve...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7998846/ https://www.ncbi.nlm.nih.gov/pubmed/33803939 http://dx.doi.org/10.3390/cancers13061296 |